Young & Partners 2025 Pharmaceutical Executive Summit: Will China Overtake the West in Drug Development?

Michael Christel, Group Managing Editor, Pharmaceutical Executive, Pharmaceutical Commerce and Applied Clinical Trials, MJH Life Sciences

Najat Khan, Chief R&D Officer and Chief Commercial Officer, Recursion Pharmaceuticals

William Pao, CEO, Revelio Therapeutics, Former Chief Development Officer, Pfizer

Peter Young, CEO and President, Young & Partners